White Paper
DWIS_Whitepaper_Cover-sm

Protect Growing CRO or Pharma Companies from Audits with Turnkey Validation

As small to medium pharmaceutical companies and contract research organizations (CROs) finalize Phase 2 clinical trials and move into Phase 3, handling increasingly more complex data in a compliant, efficient way becomes more and more difficult. 

In addition to handling the clinical trial analysis, companies must:

  • Maintain system validation
  • Provide accurate validation documentation to regulatory bodies
  • Provide access to data to multiple growing teams
  • Manage data storage
  • Handling system maintenance

Learn more by reading our study on how cloud-based, commercial solutions and technology such as virtualization are the leading solutions for growing pharma companies and CROs.

Get the White Paper

View All White Papers